KLK3 and prostate cancer: The European Randomized Study of Screening for Prostate Cancer (ERSPC) followed up with over 180,000 men undergoing regular PSA screening (between two and seven yearly intervals) with biopsies if raised and found that prostate cancer mortality was reduced in the screened arm.